REG-BARCLAYS PLC Form 8.3 - AON PLC
09/10/2020 09:50
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201009:nBw75cgx3a
Form 8.3 - AON PLC
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 08 October 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
376,871 0.16% 2,667,214 1.15%
(2) Derivatives (other than options):
538,686 0.23% 28,200 0.01%
(3) Options and agreements to
purchase/sell: 106,599 0.05% 106,599 0.05%
TOTAL:
1,022,156 0.44% 2,802,013 1.21%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 209.2800 USD
Purchase 2 208.6600 USD
Purchase 2 209.1800 USD
Purchase 3 209.6333 USD
Purchase 4 209.3425 USD
Purchase 5 209.0420 USD
Purchase 10 209.2500 USD
Purchase 13 209.7930 USD
Purchase 13 209.7007 USD
Purchase 15 209.8000 USD
Purchase 17 211.2500 USD
Purchase 17 210.5388 USD
Purchase 24 208.9341 USD
Purchase 24 208.7641 USD
Purchase 27 208.4818 USD
Purchase 36 210.6505 USD
Purchase 40 208.6852 USD
Purchase 43 210.0048 USD
Purchase 49 208.4830 USD
Purchase 50 208.1000 USD
Purchase 57 208.6122 USD
Purchase 96 209.7093 USD
Purchase 100 211.4600 USD
Purchase 100 208.7600 USD
Purchase 114 208.4192 USD
Purchase 129 210.3424 USD
Purchase 134 210.8900 USD
Purchase 163 209.1837 USD
Purchase 193 208.1429 USD
Purchase 211 208.8546 USD
Purchase 219 209.7927 USD
Purchase 304 211.2709 USD
Purchase 351 210.7798 USD
Purchase 416 208.5179 USD
Purchase 462 210.0062 USD
Purchase 503 211.3453 USD
Purchase 600 211.3925 USD
Purchase 1,206 211.1783 USD
Purchase 2,857 208.0700 USD
Purchase 3,452 210.9193 USD
Purchase 4,951 209.1313 USD
Purchase 5,219 209.3506 USD
Purchase 6,403 209.4340 USD
Purchase 8,314 209.6135 USD
Purchase 11,312 209.8773 USD
Purchase 11,577 209.4420 USD
Purchase 13,990 208.2908 USD
Purchase 46,942 209.1877 USD
Sale 1 209.8200 USD
Sale 2 209.5400 USD
Sale 3 210.9600 USD
Sale 87 209.7200 USD
Sale 100 208.7700 USD
Sale 100 209.9200 USD
Sale 132 209.8407 USD
Sale 193 208.1429 USD
Sale 200 208.1800 USD
Sale 200 208.1750 USD
Sale 200 208.6700 USD
Sale 208 208.9503 USD
Sale 217 209.6606 USD
Sale 219 209.7927 USD
Sale 300 211.2900 USD
Sale 448 208.7378 USD
Sale 450 210.1066 USD
Sale 459 210.0000 USD
Sale 552 209.0667 USD
Sale 608 209.5122 USD
Sale 770 209.0427 USD
Sale 832 209.0403 USD
Sale 1,200 209.2433 USD
Sale 1,584 209.2936 USD
Sale 1,741 210.2024 USD
Sale 1,764 209.4604 USD
Sale 2,099 209.5520 USD
Sale 2,549 209.7846 USD
Sale 2,857 208.0700 USD
Sale 4,053 209.1608 USD
Sale 5,401 208.2121 USD
Sale 5,959 210.0614 USD
Sale 6,681 211.0448 USD
Sale 7,066 209.3714 USD
Sale 7,445 209.4640 USD
Sale 8,096 209.2874 USD
Sale 9,724 209.4752 USD
Sale 10,606 209.2460 USD
Sale 10,771 209.4520 USD
Sale 11,229 208.7620 USD
Sale 14,123 208.6284 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing
and any other person relating to the voting rights of any relevant securities under any option
referred to on this form or relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is referenced. If none, this
should be stated.
NONE
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 9 Oct 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -106,599 214.5780 European Oct 20, 2020
Put Options Written 106,599 214.5780 European Oct 20, 2020
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201009005143/en/
(https://www.businesswire.com/news/home/20201009005143/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Stock Exch Notice - Admission to Trading - 17/12/2025
AnnouncementREG - Barclays PLC - Additional Listing
AnnouncementREG - Barclays PLC - Transaction in Own Shares
AnnouncementREG - Barclays PLC - Director/PDMR Shareholding
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
Announcement